Cellular Uptake Mechanisms of an Antitumor Ruthenium Compound: The Endosomal/Lysosomal System as a Target for Anticancer Metal-Based Drugs

Biological activity and cellular uptake of [Ru(η5-C5H5)(PPh3)(Me2bpy)][CF3SO3] complex

(2013) Tânia S. Morais et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Synthesis and Biological Studies of Pyrazolyl-Diamine PtIIComplexes Containing Polyaromatic DNA-Binding Groups

(2012) Sofia Gama et al.   CHEMBIOCHEM

Lysosomal pathways to cell death and their therapeutic applications

(2012) Maruša Hafner Česen et al.   EXPERIMENTAL CELL RESEARCH

Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications

(2012) Randall Logan et al.   Expert Opinion on Drug Metabolism & Toxicology

Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines

(2012) Tânia S. Morais et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

[RuII(η5-C5H5)(bipy)(PPh3)]+, a promising large spectrum antitumor agent: Cytotoxic activity and interaction with human serum albumin

(2012) Ana Isabel Tomaz et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes

(2012) Isolda Romero-Canelón et al.   Metallomics

Approaching tumour therapy beyond platinum drugs

(2011) A. Bergamo et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Cation trapping by cellular acidic compartments: Beyond the concept of lysosomotropic drugs

(2011) François Marceau et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Transport of Therapeutic Vanadium and Ruthenium Complexes by Blood Plasma Components

(2010) J. Costa Pessoa et al.   CURRENT MEDICINAL CHEMISTRY

Exploring the cellular accumulation of metal complexes

(2009) Cindy A. Puckett et al.   DALTON TRANSACTIONS

Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands

(2009) M. Helena Garcia et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

ER–Golgi network—A future target for anti-cancer therapy

(2009) Donald Wlodkowic et al.   LEUKEMIA RESEARCH

Recent developments in ruthenium anticancer drugs

(2009) Aviva Levina et al.   Metallomics

KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

(2008) Christian G. Hartinger et al.   CHEMISTRY & BIODIVERSITY

Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells

(2008) Alexander E. Egger et al.   JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY

Analytical methodologies for the determination of cisplatin

(2008) M. Espinosa Bosch et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS